Luke Nathaniel Walker's Net Worth
$217 Thousand
Who is Luke Nathaniel Walker?
Luke Nathaniel Walker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cascadian Therapeutics, Inc., Harpoon Therapeutics, Inc., Zentalis Pharmaceuticals, Inc., and Context Therapeutics Inc..
SEC CIK
Luke Nathaniel Walker's CIK is 0001701440
Past Insider Trading and Trends
2024 was Luke Nathaniel Walker's most active year for acquiring shares with 3 total transactions. Luke Nathaniel Walker's most active month to acquire stocks was the month of December. 2018 was Luke Nathaniel Walker's most active year for disposing of shares, totalling 16 transactions. Luke Nathaniel Walker's most active month to dispose stocks was the month of February. 2022 saw Luke Nathaniel Walker paying a total of $0.00 for 305,000 shares, this is the most they've acquired in one year. In 2018 Luke Nathaniel Walker cashed out on 290,638 shares for a total of $2,497.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cascadian Therapeutics, Inc. No price found
SVP, Clinical DevelopmentLuke Nathaniel Walker used to own units in Common Stock but no longer holds any shares there.acquired a total of 1,950 shares in Cascadian Therapeutics, Inc., Luke also disposed a total of 10,952 shares of Cascadian Therapeutics, Inc. equalling to $2,497.04.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.31K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +32.91% | 1.31K |
$3.92 | -$2,497.04 | 5.3K |
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) No price found
Chief Medical OfficerLuke Nathaniel Walker used to own units in Common Stock but no longer holds any shares there. From 2022 to 2024 Luke Nathaniel Walker acquired a total of 135,000 shares in Harpoon Therapeutics, Inc., Luke also disposed a total of 135,000 shares of Harpoon Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -135.00K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +575.00% | 115K |
—
|
—
| 135K |
Jan 7
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $2.96
InvestorLuke Nathaniel Walker owns 72,481 units of Common Stock which is worth $214,543.76. In the year 2024 Luke Nathaniel Walker filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 72.48K |
—
|
—
| 72.48K |
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Context Therapeutics Inc. (CNTX) Snapshot price: $2.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||